Mira Pharmaceuticals Inc (MIRA) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Mira Pharmaceuticals Inc (MIRA) following the 2026 Q2 hedge fund 13F filings?

As of today, MIRA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), MIRA gained -17.6% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Mira Pharmaceuticals Inc (MIRA)

25 + Investors. Track Smart Money conviction in MIRA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — MIRA

Based on 25 hedge funds · latest filing: 2026 Q1 · updated quarterly

➡️

No change last quarter

last 6Q

The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.

📊

High ownership — 86% of 3.0Y peak

86% of all-time peak

25 funds currently hold this stock — 86% of the 3.0-year high of 29 funds (reached 2025 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

🚀

Fast accumulation — +32% more funds vs a year ago

fund count last 6Q

+6 new funds entered over the past year (+32% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 63% buying

12 buying7 selling

Last quarter: 12 funds were net buyers (6 opened a brand new position + 6 added to an existing one). Only 7 were sellers (1 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~6 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 5 → 10 → 2 → 6. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔄

Mostly new holders — 40% entered in last year

■ 12% conviction (2yr+) ■ 48% medium ■ 40% new

Only 3 funds (12%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💎

Buying through price weakness — shares -4%, value -32%

Value

-32%

-4%

Last quarter: funds added -4% more shares while total portfolio value only changed -32%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

⚠️

Saturation — most institutions already know this story

4 → 5 → 10 → 2 → 6 new funds/Q

New funds entering each quarter: 5 → 10 → 2 → 6. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.

📊

Mixed cohorts — 8% veterans, 40% new entrants

■ 8% veterans ■ 52% 1-2yr ■ 40% new

Of 25 current holders: 2 (8%) held 2+ years, 13 held 1–2 years, 10 (40%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

✅

Strong quality — 26% AUM from major funds

26% from top-100 AUM funds

8 of 25 holders rank in the top 100 by AUM, accounting for 26% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

3.5

out of 10

Low Exit Risk

Exit risk score 3.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	25	25	-
13F Shares	2M	2M	-4.24%
Total Value	$2M	$3M	-32.16%
New Positions	6	2	+4
Increased Positions	6	8	-2
Closed Positions	6	6	-
Reduced Positions	1	2	-1
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

13F Shares

-4.24%

Total Value

$2M

$3M

-32.16%

New Positions

Increased Positions

-2

Closed Positions

Reduced Positions

-1

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

25 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MIRA. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 23 MIRA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Cross Staff Investments Inc	0.19%	359,401	$340K
2	First American Bank	0.00%	60,000	$57K
3	International Assets Investment Management, LLC	0.00%	35,000	$33K
4	Cary Street Partners Financial LLC	0.00%	10,000	$9K
5	XTX Topco Ltd	0.00%	16,374	$15K
6	Captrust Financial Advisors	0.00%	90,645	$86K
7	Commonwealth Equity Services, LLC	0.00%	53,189	$50K
8	Vanguard Fiduciary Trust Co	0.00%	170,668	$162K
9	Fifth Third Bancorp	0.00%	20,000	$19K
10	Federation des caisses Desjardins du Quebec	0.00%	8,000	$8K
11	Hrt Financial LP	0.00%	13,450	$12K
12	Mariner, LLC	0.00%	16,500	$16K
13	Vanguard Capital Management LLC	0.00%	751,801	$712K
14	Tower Research Capital LLC (TRC)	0.00%	517	—
15	Steward Partners Investment Advisory, LLC	0.00%	1,000	—
16	BlackRock, Inc.	0.00%	244,622	$232K
17	Osaic Holdings, INC.	0.00%	2,000	$2K
18	Citadel Advisors LLC	0.00%	18,661	$18K
19	Susquehanna International Group, LLP	0.00%	18,566	$18K
20	Citigroup Inc	0.00%	1,207	$1K
21	UBS Group AG	0.00%	1,772	$2K
22	Caitong International Asset Management Co., Ltd	0.00%	1	—
23	Barclays plc	0.00%	159	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Mira Pharmaceuticals Inc (MIRA)

What does the Smart Money Trend signal show for MIRA?

No change last quarter: The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.

What is the institutional breadth score for MIRA?

More buyers than sellers — 63% buying: Last quarter: 12 funds were net buyers (6 opened a brand new position + 6 added to an existing one). Only 7 were sellers (1 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for MIRA holders?

Strong quality — 26% AUM from major funds: 8 of 25 holders rank in the top 100 by AUM, accounting for 26% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held MIRA?

Mostly new holders — 40% entered in last year: Only 3 funds (12%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Mira Pharmaceuticals Inc (MIRA) following the 2026 Q2 hedge fund 13F filings?

As of today, MIRA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), MIRA has gained -17.6% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Mira Pharmaceuticals Inc (MIRA)

Smart Money Signals — MIRA

No change last quarter

High ownership — 86% of 3.0Y peak

Fast accumulation — +32% more funds vs a year ago

More buyers than sellers — 63% buying

Steady new buyers — ~6 new funds per quarter

Mostly new holders — 40% entered in last year

Buying through price weakness — shares -4%, value -32%

Saturation — most institutions already know this story

Mixed cohorts — 8% veterans, 40% new entrants

Strong quality — 26% AUM from major funds

Institutional Sentiment Summary — MIRA

Hedge Fund Ownership: MIRA

Market Analysis: MIRA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: MIRA

Is It Too Late to Buy Mira Pharmaceuticals Inc (MIRA) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: MIRA

Statistics: MIRA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Mira Pharmaceuticals Inc (MIRA)

Welcome to 13Foresight!